CIK 0001590877
- Non-accelerated filer
- Smaller reporting company
REGENXBIO Inc.
Sign in to watch- Ticker
- RGNX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 471851754
- Phone
- +1 240-552-8181
- Business address
- 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
- Former names
- ReGenX Biosciences, LLC
- Open-market buys, last 90 days
- $949,381
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-11-27 | Simpson Curran SVP, Technical Operations | Sale | −2,000 | $29.31 | $59K | 39,500 |
| 2017-11-27 | Simpson Curran SVP, Technical Operations | Exercise or conversion · Stock Option (Right to Buy) | −2,000 | 8,000 | ||
| 2017-11-20 | Mills Kenneth T. President and CEO | Exercise or conversion | +30,000 | $0.85 | $26K | 128,530 |
| 2017-11-20 | Mills Kenneth T. President and CEO | Sale | −10,000 | $27.71 | $277K | 118,530 |
| 2017-11-20 | Mills Kenneth T. President and CEO | Exercise or conversion · Employee Stock Option (Right to Buy) | −30,000 | 529,670 | ||
| 2017-11-15 | Vasista Vittal Chief Financial Officer | Sale | −5,000 | $25.30 | $127K | 87,283 |
| 2017-10-20 | Mills Kenneth T. President and CEO | Sale | −9,800 | $32.61 | $320K | 98,730 |
| 2017-10-20 | Mills Kenneth T. President and CEO | Sale | −200 | $33.03 | $7K | 98,530 |
| 2017-10-16 | Vasista Vittal Chief Financial Officer | Sale | −5,000 | $33.25 | $166K | 92,283 |
| 2017-10-11 | HAYDEN DONALD J JR Director | Exercise or conversion | +20,000 | $0.85 | $17K | 20,000 |
| 2017-10-11 | HAYDEN DONALD J JR Director | Sale | −20,000 | $34.95 | $699K | 0 |
| 2017-10-11 | HAYDEN DONALD J JR Director | Exercise or conversion · Stock Option (Right to Buy) | −20,000 | 234,100 | ||
| 2017-09-27 | HAYDEN DONALD J JR Director | Exercise or conversion | +20,000 | $0.85 | $17K | 20,000 |
| 2017-09-27 | HAYDEN DONALD J JR Director | Sale | −20,000 | $32.45 | $649K | 0 |
| 2017-09-27 | HAYDEN DONALD J JR Director | Exercise or conversion · Stock Option (Right to Buy) | −20,000 | 254,100 | ||
| 2017-09-20 | Mills Kenneth T. President and CEO | Sale | −9,900 | $29.32 | $290K | 108,630 |
| 2017-09-20 | Mills Kenneth T. President and CEO | Sale | −100 | $30.05 | $3K | 108,530 |
| 2017-09-18 | HAYDEN DONALD J JR Director | Exercise or conversion | +20,000 | $0.85 | $17K | 20,000 |
| 2017-09-18 | HAYDEN DONALD J JR Director | Sale | −20,000 | $29.95 | $599K | 0 |
| 2017-09-18 | HAYDEN DONALD J JR Director | Exercise or conversion · Stock Option (Right to Buy) | −20,000 | 274,100 |
Page 45 of 56 · 1,104 trades